Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
2 hedge funds and large institutions have $845K invested in Osiris Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
49% more capital invested
Capital invested by funds: $567K → $845K (+$278K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$14.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIM
1
Freedom Investment Management
Hartford,
Connecticut
| $740K | +$14.1K | +1,599 | +2% |
|
2
Public Employees Retirement Association of Colorado
Denver,
Colorado
| $105K | – | – | – |
|
OSIR Hedge Fund Activity: Q1 2018 in Review
2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q1 2018, worth a combined $845K — up 49% from $567K a quarter earlier.
Fund positioning in OSIR was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Freedom Investment Management, adding an estimated $14.1K.
- 2 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $845K of Osiris Therapeutics, Inc. Common Stock stock for Q1 2018, up 49% quarter-over-quarter.
- 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q1 2018 and 0 closed out.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q1 2018 was Freedom Investment Management, an estimated $14.1K added.
Based on aggregated 13F filings for Q1 2018.